ArticlePaediatric respiratory reviews2011
Diagnosing and preventing chronic suppurative lung disease (CSLD) and bronchiectasis.
Article in Paediatric respiratory reviews, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02258763 (Pneumonia in Children), which is not on this map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Pneumonia in Children: Aetiology, Ideal Antibiotic Duration, Quality of Life
Who cites it
22 citing papers in PubMed, 63 citations in OpenAlex.
- Trial
- Trial
- Time to re-set our thinking about airways disease: lessons from history, the resurgence of chronic bronchitis / PBB and modern concepts in microbiology.Frontiers in pediatrics · 2024Review
- Bronchiectasis in children in a high HIV and tuberculosis prevalence setting.African journal of thoracic and critical care medicine · 2024Article
- Lower Respiratory Tract Infection in Children: When Are Further Investigations Warranted?Frontiers in pediatrics · 2021Article
- Bronchiectasis in Primary Antibody Deficiencies: A Multidisciplinary Approach.Frontiers in immunology · 2020Review
- Bacterial pneumonia and its associated factors in children from a developing country: A prospective cohort study.PloS one · 2020Article
- Noncystic Fibrosis Bronchiectasis: Evaluation of an Extensive Diagnostic Protocol in Determining Pediatric Lung Disease Etiology.Pediatric allergy, immunology, and pulmonology · 2019Article
- 'Dry' and 'wet' cough: how reliable is parental reporting?BMJ open respiratory research · 2019Article
- Phenotypic presentation of chronic cough in children.Journal of thoracic disease · 2017Article
- Editorial: Chronic Suppurative Lung Disease and Bronchiectasis in Children and Adolescents.Frontiers in pediatrics · 2017Article
- Chronic suppurative lung disease in adults.Journal of thoracic disease · 2016Article
- Children with recurrent pneumonia and non-cystic fibrosis bronchiectasis.Italian journal of pediatrics · 2016Article
- Update on Pediatric Cough.Lung · 2016Review
- A review of the role ofPneumonia (Nathan Qld.) · 2015Review
- Article
- Toward making inroads in reducing the disparity of lung health in Australian indigenous and new zealand māori children.Frontiers in pediatrics · 2015Review
- Improving the Diagnosis, Management, and Outcomes of Children with Pneumonia: Where are the Gaps?Frontiers in pediatrics · 2013Review
- Non invasive assessment of lung disease in ataxia telangiectasia by high-field magnetic resonance imaging.Journal of clinical immunology · 2013Article
- Specialty grand challenge - pediatric pulmonology.Frontiers in pediatrics · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current diagnostic labelling of childhood bronchiectasis by radiology has substantial limitations. These include the requirement for two high resolution computerised tomography [HRCT] scans (with associated adversity of radiation) if criteria is adhered to, adoption of radiological criteria for children from adult data, relatively high occurrence of false negative, and to a smaller extent false positive, in conventional HRCT scans when compared to multi-detector CT scans, determination of irreversible airway dilatation, and absence of normative data on broncho-arterial ratio in children. A paradigm presenting a spectrum related to airway bacteria, with associated degradation and inflammation products causing airway damage if untreated, entails protracted bacterial bronchitis (at the mild end) to irreversible airway dilatation with cystic formation as determined by HRCT (at the severe end of the spectrum). Increasing evidence suggests that progression of airway damage can be limited by intensive treatment, even in those predestined to have bronchiectasis (eg immune deficiency). Treatment is aimed at achieving a cure in those at the milder end of the spectrum to limiting further deterioration in those with severe 'irreversible' radiological bronchiectasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.